551
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation

, MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, , MD & , MD, PhD show all
Pages 167-172 | Received 30 Jul 2014, Accepted 17 Sep 2014, Published online: 17 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Antonio Vitale, Valeria Caggiano, Virginia Berlengiero, Maria Orsetta Perfetti, Jurgen Sota, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2023) Comparing biologic options for the management of Behcet’s disease-related uveitis. Expert Review of Clinical Immunology 19:3, pages 315-328.
Read now
Carla Gaggiano, Jurgen Sota, Stefano Gentileschi, Valeria Caggiano, Salvatore Grosso, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2020) The current status of biological treatment for uveitis. Expert Review of Clinical Immunology 16:8, pages 787-811.
Read now
Maria Esposito, Francesco Carubbi, Alessandro Giunta, Alessia Alunno, Roberto Giacomelli & Maria Concetta Fargnoli. (2020) Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis. Expert Review of Clinical Immunology 16:2, pages 119-128.
Read now
Maria Soledad Ormaechea, Muhammad Hassan, Neil Onghanseng, Jung Hyun Park, Sarakshi Mahajan, Khalid Yusuf Al-Kirwi, Gunay Uludag, Muhammad Sohail Halim, Ariel Schlaen, Yasir J Sepah, Diana V Do & Quan Dong Nguyen. (2019) Safety of systemic therapy for noninfectious uveitis. Expert Opinion on Drug Safety 18:12, pages 1219-1235.
Read now
Alfredo Adán, Aina Moll-Udina, Carmen Alba-Linero, Juan Pablo Figueroa-Vercellino & Victor Llorenç. (2019) Recent progress in the treatment of uveitic macular edema. Expert Review of Ophthalmology 14:4-5, pages 227-236.
Read now
Uwe Pleyer, Dominika Pohlmann, Esra Kardeş, Denis Poddubnyy & Judith Rademacher. (2019) Emerging drugs for the treatment of noninfectious uveitis. Expert Opinion on Emerging Drugs 24:3, pages 173-190.
Read now
Sara Touhami, Eléonore Diwo, Pascal Sève, Salim Trad, Philip Bielefeld, Damien Sène, Sebastien Abad, Antoine Brézin, Pierre Quartier, Isabelle Koné Paut, Michel Weber, Christophe Chiquet, Marie-Hélène Errera, Jérémie Sellam, Patrice Cacoub, Gilles Kaplanski, Laurent Kodjikian, Bahram Bodaghi & David Saadoun. (2019) Expert opinion on the use of biological therapy in non-infectious uveitis. Expert Opinion on Biological Therapy 19:5, pages 477-490.
Read now
Artemis Matsou & Konstantinos T Tsaousis. (2018) Management of chronic ocular sarcoidosis: challenges and solutions. Clinical Ophthalmology 12, pages 519-532.
Read now
Giuseppe Lopalco, Giacomo Emmi, Stefano Gentileschi, Silvana Guerriero, Antonio Vitale, Elena Silvestri, Matteo Becatti, Iacopo Cavallo, Claudia Fabiani, Bruno Frediani, Florenzo Iannone & Luca Cantarini. (2017) Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: A multicenter retrospective observational study. Modern Rheumatology 27:6, pages 1031-1035.
Read now

Articles from other publishers (15)

Qi Jiang, Zhaohuai Li, Tianyu Tao, Runping Duan, Xianggui Wang & Wenru Su. (2021) TNF-α in Uveitis: From Bench to Clinic. Frontiers in Pharmacology 12.
Crossref
Lucia Novelli, Ennio Lubrano, Vincenzo Venerito, Fabio Massimo Perrotta, Francesca Marando, Giacomo Curradi & Florenzo Iannone. (2021) Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk. Frontiers in Medicine 8.
Crossref
Lorena Olivares-González, Sheyla Velasco, Isabel Campillo & Regina Rodrigo. (2021) Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies. International Journal of Molecular Sciences 22:4, pages 2096.
Crossref
Denis Wakefield, Daniel Clarke & Peter McCluskey. (2021) Recent Developments in HLA B27 Anterior Uveitis. Frontiers in Immunology 11.
Crossref
Alejandro Gómez-Gómez, Estíbaliz Loza, Mª Piedad Rosario, Gerard Espinosa, José M García Ruiz de Morales, José M Herrera, Santiago Muñoz-Fernández, Luis Rodríguez-Rodríguez & Miguel Cordero-Coma. (2020) Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review. Seminars in Arthritis and Rheumatism 50:6, pages 1299-1306.
Crossref
Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, Georgina Maalouf, Sara Touhami, Patrice Cacoub, Bahram Bodaghi & David Saadoun. (2020) Biotherapies in Uveitis. Journal of Clinical Medicine 9:11, pages 3599.
Crossref
Yael Sharon & David S. Chu. (2020) Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis. American Journal of Ophthalmology Case Reports 18, pages 100633.
Crossref
Rodrigo A. Valenzuela, Iván Flores, Beatriz Urrutia, Francisca Fuentes, Pablo E. Sabat, Carolina Llanos, Loreto Cuitino & Cristhian A. Urzua. (2020) New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview. Frontiers in Pharmacology 11.
Crossref
Judy L. Chen, Ann-Marie Lobo-Chan, Robison Vernon Paul Chan & Pooja Bhat. 2019. Advances in the Diagnosis and Management of Uveitis. Advances in the Diagnosis and Management of Uveitis.
Martina Biggioggero, Chiara Crotti, Andrea Becciolini, Elisabetta Miserocchi & Ennio Giulio Favalli. (2018) The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future. BioMed Research International 2018, pages 1-11.
Crossref
Obinna C. Ubah, John Steven, Marina Kovaleva, Laura Ferguson, Charlotte Barelle, Andrew J. R. Porter & Caroline J. Barelle. (2017) Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development. Frontiers in Immunology 8.
Crossref
M. Rudwaleit, J. T. Rosenbaum, R. Landewé, H. Marzo‐Ortega, J. Sieper, D. van der Heijde, O. Davies, H. Bartz, B. Hoepken, T. Nurminen & A. Deodhar. (2016) Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis. Arthritis Care & Research 68:6, pages 838-844.
Crossref
Leyre Riancho-Zarrabeitia, Vanesa Calvo-Río, Ricardo Blanco, Marina Mesquida, Alfredo M. Adan, José M. Herreras, Ángel Aparicio, Diana Peiteado-Lopez, Miguel Cordero-Coma, José Luis García Serrano, Norberto Ortego-Centeno, Olga Maíz, Ana Blanco, Juan Sánchez-Bursón, Senén González-Suárez, Alejandro Fonollosa, Montserrat Santos-Gómez, Carmen González-Vela, Javier Loricera, Trinitario Pina & Miguel A. González-Gay. (2015) Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. Seminars in Arthritis and Rheumatism 45:3, pages 361-368.
Crossref
Olga Maiz Alonso, Ana Carmen Blanco Esteban, Cesar Antonio Egües Dubuc & David Martinez Zabalegui. (2015) Effectiveness of Certolizumab Pegol in Chronic Anterior Uveitis Associated to Crohn's Disease and Ankylosing Spondylitis. Reumatología Clínica (English Edition) 11:3, pages 189-190.
Crossref
Olga Maiz Alonso, Ana Carmen Blanco Esteban, Cesar Antonio Eg?es Dubuc & David Martinez Zabalegui. (2015) Efectividad del certolizumab pegol en el tratamiento de la uve?tis anterior cr?nica asociada a enfermedad de Crohn y espondilitis anquilosante. Reumatolog?a Cl?nica 11:3, pages 189-190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.